Interv Akut Kardiol. 2005;4(4):224-228

THROMBOELASTOGRAPHY FOR MONITORING OF HAEMOSTASIS IN CARDIAC SURGERY

Roman Hájek1,2, Radek Zezula2, Ivo Fluger2, Jana Růžičková2
1 Interní hematoonkologická klinika LF MU a FN Brno
2 Kardiochirurgická klinika FN a LF UP v Olomouci

Thromboelastography (TEG) is extensively used method of haemostasis monitoring during cardiac surgery these days. This article explores mechanisms of haemostasis activation during cardiopulmonary bypass and informs about history and priciples of TEG and its using in cardiac surgery.

Keywords: Key words: thromboelastography, cardiopulmonary bypass, haemostasis.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hájek R, Zezula R, Fluger I, Růžičková J. THROMBOELASTOGRAPHY FOR MONITORING OF HAEMOSTASIS IN CARDIAC SURGERY. Interv Akut Kardiol. 2005;4(4):224-228.
Download citation

References

  1. Wulf D. Cardiac surgery and the coagulation system. Current Opinion in Anaesthesiology, 2000; 13: 27-34. Go to original source... Go to PubMed...
  2. Shore-Lessersson L, Gravlee GP, Horrow JP. Coagulation management during cardiopulmonary bypass, In: Hensley FA et al.: A practical approach to cardiac anesthesia. LWW, Philadelphia, 2003: 504-509.
  3. Shore-Lessersson L, Gravlee GP. Anticoagulation for cardiopulmonary bypass, LWW, Philadelphia, 2000: 423-463.
  4. Holloway PAH: POCT in intensive care. In: Kost GJ et al.: Principles and practice of point-of-care testing, LWWW, Philadelphia, 2002: 133-156.
  5. Samama CM. Assessment of the coagulation in perioperative setting. Refresher course lecture, ESA Annual Meeting, Vienna, 2000.
  6. Despotis GJ, Joist H, Goodnough LT. Monitoring of hemostasis in cardiac surgical patients: impact of POCT on blood loss and transfusion outcomes. Clinical Chemistry, 1997: 43. Go to original source...
  7. Prisco D, Panciccia R. Point-of-care testing of hemostasis in cardiac surgery. Thrombosis Journal 2003: 1.1. Go to original source... Go to PubMed...
  8. Roizen MF. Preoperative evaluation. In: Miller RD: Miller´s Anesthesia, 6th edition, Churchill Livingstone, Philadelphia, 2005: 954-961.
  9. Mark JB, Slaughter TF. Coagulation Monitoring. In: Miller RD: Millerś Anesthesia 6th edition, Churchill Livingstone, Philadelphia, 2005: 1338-1343.
  10. Spiess BD. Coagulation dysfunction after cardiopulmonary bypass. In: Williams JP, ed. Postoperative management of the cardiac surgical patients, Churchill Livingstone, New York, 1996: 221-225.
  11. Kang YG, Martin DJ, Marquez JH, et al. Intraoperative changes in blood coagulation and thromboelstographic monitoring in liver transplantation. Anesth Analg 1985; 64: 888-896. Go to original source... Go to PubMed...
  12. Gravlee G. Predictive value of blood clotting tests in cardiac surgical patient, Ann Thor Surg 1994; 58: 216-221. Go to original source... Go to PubMed...
  13. Spiess BD, Tuman KJ, Mc Carthy RJ, et al. Thromboelastography as an indicator of post cardiopulmonary bypass coagulopathies, J Clin Monitor 1987; 3: 25-30. Go to original source... Go to PubMed...
  14. Von Kier S. Reduced hemostatic factor transfusion using heparinase modified thromboelastography during cardiopulmonary bypass, Anethesiology, V 89: 3A, 1998: A 911. Go to original source...
  15. Shore-Lesserson L, Manspeizer HE, Deperio M, et al. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients, Anesth Analg, 1999; 88: 312-319. Go to original source... Go to PubMed...
  16. Gillies BS, Spiess BD, Chandler W. Changes in transfusion therapy and reexploration rate after institution blood management program in cardias surgical patients, J Cardiothorac.Vasc. Anesth, 1995; 9: 168-173. Go to original source... Go to PubMed...
  17. Horáček M, Cvachovec K. The effect of cardiopulmonary bypass with hollow fibre membrane oxygenator on blood clotting measured by thromboelastography, Physiol Res 2002; 51: 141-150.




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.